Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: Innovations HUB | 2026 Innovations [Non-CME]

Panel Discussion | Potpourri of Cardiology - Innovations in Heart Failure and Structural Heart AI

Sunday, March 8, 2026
5:35 PM - 5:50 PM EST
Location: International Ballroom West

    Moderator(s)

  • Nabil Dib, MD, MSc, FACC

    Director Cardiovascular Research
    Mercy Gilbert Medical Center/Dignity Health
    Gilbert, Arizona, United States

    Disclosure(s): No financial relationships to disclose

  • Stanton J. Rowe, PhD

    CEO
    Nidus Biomedical
    Irvine, California, United States

    Disclosure(s): No financial relationships to disclose

  • Robert S. Schwartz, MD, FACC, FSCAI

    President
    DeHaan Center for Medical Innovation
    Longboat Key, Florida, United States

    Disclosure(s): Autonomix LLC: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

    • Panel Discussant(s)

  • Takashi Akasaka, MD, PhD

    Senior Consultant
    Nishinomiya Watanabe Cardiovascular Cerebral Center
    Nishinomiya, Hyogo, Japan

    Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 18, 2025)

  • Mehmet Cilingiroglu, MD

    Professor
    University of Hawaii John Burns School of Medicine
    San Diego, California, United States

    Disclosure(s): No financial relationships to disclose

  • Lakshmi P. Dasi, PhD, FACC

    Professor
    Georgia Tech / Emory University

    Disclosure information not submitted.

  • William A. Gray, MD, FSCAI

    System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
    Main Line Health
    Wynnewood, Pennsylvania, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Chaim Shaul Lotan, MD

    Chief Innovation Officer
    Hadassah-Hebrew University Medical Center
    Jerusalem, Israel

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Nabil Dib, MD, MSc, FACC: No financial relationships to disclose
Stanton J. Rowe, PhD: No financial relationships to disclose
Robert S. Schwartz, MD, FACC, FSCAI: Autonomix LLC: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Takashi Akasaka, MD, PhD: Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 18, 2025)
Mehmet Cilingiroglu, MD: No financial relationships to disclose
William A. Gray, MD, FSCAI: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
Chaim Shaul Lotan, MD: No financial relationships to disclose